Table I.
Clinical background of the patients.
| Clinical characteristic | Result |
|---|---|
| Total no. of patients (M/F) | 85 (52/33) |
| Age [years (range)] | 34.6 (16–69) |
| Disease duration [months (range)] | 58.4 (0.3–267.7) |
| Seo index (no. of patients <220/≥220) | 45/40 |
| Disease severity (no. of patients with left-sided colitis/pancolitis) | 29/56 |
| Disease course (no. of patients with first attack/chronic continuous/relapse remitting UC) | 9/23/53 |
| Previous treatment (no. of patients treated with cytapheresis therapy/AZA or 6-MP/biologics) | 42/29/4 |
| Hematocrit [mean % (range)] | 34.8 (18.3–47.8) |
| White blood cell count/mm3 [mean (range)] | 9,468 (3,000–21,200) |
| Lymphocyte count/mm3 [mean (range)] | 1,189 (162–3,163) |
| Platelets [×103/mm3; mean (range)] | 341.2 (44–933) |
| Albumin g/dl [mean (range)] | 3.3 (1.8–4.5) |
| C-reactive protein mg/dl [mean (range)] | 2.7 (0.0–16.6) |
| O-PNI [mean (range)] | 39.4 (22.7–53.1) |
| C7-HRP (no. of patients with positive/negative C7-HRP) | 23/62 |
| PSL≥10,000 mg (no. of patients with/without PSL≥10,000 mg) | 12/73 |
Left-sided colitis refers to patients who have mucosal lesions restricted to the rectum, sigmoid colon and descending colon. M, male; F, female; AZA, azathioprine; 6-MP, 6-mercaptopurine; O-PNI, onodera-prognostic nutritional index; C7-HRP, cytomegalovirus antigenemia; PSL, prednisolone.